Gelone Steven P. 4
4 · Nabriva Therapeutics plc · Filed Oct 4, 2022
Insider Transaction Report
Form 4
Gelone Steven P.
Chief Development Officer
Transactions
- Tax Payment
Ordinary Shares
2022-09-30$2.08/sh−3$6→ 14,449 total
Footnotes (2)
- [F1]These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.
- [F2]The number of ordinary shares reported on this Form 4 reflects a 1-for-25 reverse stock split effected on September 15, 2022.